Access cutting-edge hidradenitis suppurativa treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access hidradenitis suppurativa specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hidradenitis suppurativa treatment provided free
Hidradenitis suppurativa (HS) is an inflammatory skin disease that causes painful lesions in the axilla (underarm), inguinal (groin) and anogenital (anal/genital) regions. This study will assess how safe and effective upadacitinib is in treating adult and adolescent participants with moderate to severe HS who have failed to respond to or are intolerant of anti-tumor necrosis factor (TNF) therapy. Adverse events and change in disease activity will be assessed. Upadacitinib is an approved drug fo
Sponsor: AbbVie
Check if you qualify for this hidradenitis suppurativa clinical trial in Phoenix, AZ
If you're searching for hidradenitis suppurativa treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hidradenitis suppurativa specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.